Immuno-Mycologics, Inc. is recalling 101 units of its Immy Myco DDR Trident Neutralization Buffer B used for laboratory diagnosis of Mycobacterium species. The recall was initiated because the buffer may contain contaminants that could compromise testing results. This diagnostic laboratory product was distributed nationwide to specific states including California, Texas, and Washington between March and May 2026.
The presence of contaminants in the neutralization buffer can lead to inaccurate laboratory test results, potentially causing incorrect diagnoses or delays in treatment for Mycobacterium infections.
For processing of clinical specimens for Mycobacterium spp. diagnosis
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.